211 related articles for article (PubMed ID: 25549970)
21. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?
Galea E; Launay N; Portero-Otin M; Ruiz M; Pamplona R; Aubourg P; Ferrer I; Pujol A
Biochim Biophys Acta; 2012 Sep; 1822(9):1475-88. PubMed ID: 22353463
[TBL] [Abstract][Full Text] [Related]
22. Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2).
Fourcade S; Savary S; Gondcaille C; Berger J; Netik A; Cadepond F; El Etr M; Molzer B; Bugaut M
Mol Pharmacol; 2003 Jun; 63(6):1296-303. PubMed ID: 12761339
[TBL] [Abstract][Full Text] [Related]
23. Novel Therapeutic Targets and Drug Candidates for Modifying Disease Progression in Adrenoleukodystrophy.
Pujol A
Endocr Dev; 2016; 30():147-60. PubMed ID: 26684655
[TBL] [Abstract][Full Text] [Related]
24. Therapy of X-linked adrenoleukodystrophy.
Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
[TBL] [Abstract][Full Text] [Related]
25. Cyclophilin D as a potential target for antioxidants in neurodegeneration: the X-ALD case.
López-Erauskin J; Ferrer I; Galea E; Pujol A
Biol Chem; 2013 May; 394(5):621-9. PubMed ID: 23492556
[TBL] [Abstract][Full Text] [Related]
26. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
[TBL] [Abstract][Full Text] [Related]
27. Anti-oxidant MitoQ rescue of AWB chemosensory neuron impairment in a
Guha S; Pujol A; Dalfo E
MicroPubl Biol; 2021 Jan; 2021():. PubMed ID: 33474532
[TBL] [Abstract][Full Text] [Related]
28. mTOR Overactivation and Compromised Autophagy in the Pathogenesis of Pulmonary Fibrosis.
Gui YS; Wang L; Tian X; Li X; Ma A; Zhou W; Zeng N; Zhang J; Cai B; Zhang H; Chen JY; Xu KF
PLoS One; 2015; 10(9):e0138625. PubMed ID: 26382847
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of mammalian target of rapamycin with rapamycin reverses hypertrophic cardiomyopathy in mice with cardiomyocyte-specific knockout of PTEN.
Xu X; Roe ND; Weiser-Evans MC; Ren J
Hypertension; 2014 Apr; 63(4):729-39. PubMed ID: 24446058
[TBL] [Abstract][Full Text] [Related]
30. Rapamycin promotes autophagy and reduces neural tissue damage and locomotor impairment after spinal cord injury in mice.
Sekiguchi A; Kanno H; Ozawa H; Yamaya S; Itoi E
J Neurotrauma; 2012 Mar; 29(5):946-56. PubMed ID: 21806471
[TBL] [Abstract][Full Text] [Related]
31. Reproductive function in men affected by X-linked adrenoleukodystrophy/adrenomyeloneuropathy.
Stradomska TJ; Kubalska J; Janas R; Tylki-Szymanska A
Eur J Endocrinol; 2012 Feb; 166(2):291-4. PubMed ID: 22048970
[TBL] [Abstract][Full Text] [Related]
32. Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells.
Aryal P; Kim K; Park PH; Ham S; Cho J; Song K
FEBS J; 2014 Oct; 281(20):4644-58. PubMed ID: 25132405
[TBL] [Abstract][Full Text] [Related]
33. Neurodegeneration in a Drosophila model of adrenoleukodystrophy: the roles of the Bubblegum and Double bubble acyl-CoA synthetases.
Sivachenko A; Gordon HB; Kimball SS; Gavin EJ; Bonkowsky JL; Letsou A
Dis Model Mech; 2016 Apr; 9(4):377-87. PubMed ID: 26893370
[TBL] [Abstract][Full Text] [Related]
34. X-linked adrenoleukodystrophy: are signs of hypogonadism always due to testicular failure?
Karapanou O; Vlassopoulou B; Tzanela M; Papadopoulos D; Angelidakis P; Michelakakis H; Ioannidis G; Mihalatos M; Kamakari S; Tsagarakis S
Hormones (Athens); 2014; 13(1):146-52. PubMed ID: 24722136
[TBL] [Abstract][Full Text] [Related]
35. High-dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy.
Fourcade S; Goicoechea L; Parameswaran J; Schlüter A; Launay N; Ruiz M; Seyer A; Colsch B; Calingasan NY; Ferrer I; Beal MF; Sedel F; Pujol A
Brain Pathol; 2020 Sep; 30(5):945-963. PubMed ID: 32511826
[TBL] [Abstract][Full Text] [Related]
36. Autophagic clearance of aggregate-prone proteins associated with neurodegeneration.
Sarkar S; Ravikumar B; Rubinsztein DC
Methods Enzymol; 2009; 453():83-110. PubMed ID: 19216903
[TBL] [Abstract][Full Text] [Related]
37. Turning skin into brain: using patient-derived cells to model X-linked adrenoleukodystrophy.
Parent JM
Ann Neurol; 2011 Sep; 70(3):350-2. PubMed ID: 21905077
[No Abstract] [Full Text] [Related]
38. Beam Me In: Thyroid Hormone Analog Targets Alternative Transporter in Mouse Model of X-Linked Adrenoleukodystrophy.
Milanesi A; Brent GA
Endocrinology; 2017 Apr; 158(5):1116-1119. PubMed ID: 28609836
[No Abstract] [Full Text] [Related]
39. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
Kruska N; Schönfeld P; Pujol A; Reiser G
Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: A paradigm for axonal degeneration.
Fourcade S; Ferrer I; Pujol A
Free Radic Biol Med; 2015 Nov; 88(Pt A):18-29. PubMed ID: 26073123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
